Tamura R. Current understanding of neurofibromatosis type 1, 2, and schwannomatosis. Int J Mol Sci. 2021;22(11):5850. https://doi.org/10.3390/ijms22115850. PMID: 34072574; PMCID: PMC8198724.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sabbagh A, Pasmant E, Imbard A, Luscan A, Soares M, Blanché H, Laurendeau I, Ferkal S, Vidaud M, Pinson S, Bellanné-Chantelot C, Vidaud D, Parfait B, Wolkenstein P. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat. 2013;34(11):1510–8. https://doi.org/10.1002/humu.22392. Epub 2013 Aug 26.

Article  CAS  PubMed  Google Scholar 

Sørensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986;314(16):1010–5. https://doi.org/10.1056/NEJM198604173141603.

Article  PubMed  Google Scholar 

Belakhoua SM, Rodriguez FJ. Diagnostic pathology of tumors of peripheral nerve. Neurosurgery. 2021;88(3):443–56. https://doi.org/10.1093/neuros/nyab021. PMID: 33588442; PMCID: PMC7884141.

Article  PubMed  PubMed Central  Google Scholar 

Ahlawat S, Chhabra A, Blakely J. Magnetic resonance neurography of peripheral nerve tumors and tumorlike conditions. Neuroimaging Clin N Am. 2014;24(1):171–92. https://doi.org/10.1016/j.nic.2013.03.035. Epub 2013 May 30.

Article  PubMed  Google Scholar 

Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S, Merker VL, Munn LL, Muzikansky A, Askenazi M, Nguyen R, Wenzel R, Mautner VF. Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS One. 2012;7(4):e35711. https://doi.org/10.1371/journal.pone.0035711. Epub 2012 Apr 27. PMID: 22558206; PMCID: PMC3338705.

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

Monroe CL, Dahiya S, Gutmann DH. Dissecting clinical heterogeneity in neurofibromatosis type 1. Annu Rev Pathol. 2017;24:53–74. https://doi.org/10.1146/annurev-pathol-052016-100228.

Article  CAS  Google Scholar 

Watson KL, Al Sannaa GA, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Ashleigh Guadagnolo B, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE. Patterns of recurrence and survival in sporadic, neurofibromatosis type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. J Neurosurg. 2017;126(1):319–29. https://doi.org/10.3171/2015.12.JNS152443. Epub 2016 Apr 1. PMID: 27035165; PMCID: PMC5045773.

Article  PubMed  Google Scholar 

Lassmann H, Jurecka W, Lassmann G, Gebhart W, Matras H, Watzek G. Different types of benign nerve sheath tumors. Light microscopy, electron microscopy and autoradiography. Virchows Arch A Pathol Anat Histol. 1977;375(3):197–210. https://doi.org/10.1007/BF01102988.

Article  CAS  PubMed  Google Scholar 

Tucker T, Wolkenstein P, Revuz J, Zeller J, Friedman JM. Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology. 2005;65(2):205–11. https://doi.org/10.1212/01.wnl.0000168830.79997.13.

Article  CAS  PubMed  Google Scholar 

Ehara Y, Koga M, Imafuku S, Yamamoto O, Yoshida Y. Distribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1. J Dermatol. 2020;47(2):190–2. https://doi.org/10.1111/1346-8138.15194. Epub 2019 Dec 17.

Article  PubMed  Google Scholar 

Schaefer IM, Fletcher CD. Malignant peripheral nerve sheath tumor (MPNST) arising in diffuse-type neurofibroma: clinicopathologic characterization in a series of 9 cases. Am J Surg Pathol. 2015;39(9):1234–41.

Article  PubMed  Google Scholar 

Ahlawat S, Blakeley JO, Langmead S, Belzberg AJ, Fayad LM. Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Skeletal Radiol. 2020;49(2):199–219. https://doi.org/10.1007/s00256-019-03290-1. Epub 2019 Aug 8.

Article  PubMed  Google Scholar 

Azizi AA, Slavc I, Theisen BE, Rausch I, Weber M, Happak W, Aszmann O, Hojreh A, Peyrl A, Amann G, Benkoe TM, Wadsak W, Kasprian G, Staudenherz A, Hacker M, Traub-Weidinger T. Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [18 F]FDG-PET imaging. Is it of value in asymptomatic patients? Pediatr Blood Cancer. 2018;65(1). https://doi.org/10.1002/pbc.26733.

Spurlock G, Knight SJ, Thomas N, Kiehl TR, Guha A, Upadhyaya M. Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings. J Cancer Res Clin Oncol. 2010;136(12):1869–80. https://doi.org/10.1007/s00432-010-0846-3. Epub 2010 Mar 15.

Article  CAS  PubMed  Google Scholar 

Mautner VF, Asuagbor FA, Dombi E, Fünsterer C, Kluwe L, Wenzel R, Widemann BC, Friedman JM. Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncol. 2008;10(4):593–8. https://doi.org/10.1215/15228517-2008-011. Epub 2008 Jun 17. PMID: 18559970; PMCID: PMC2666233.

Article  PubMed  PubMed Central  Google Scholar 

Nguyen R, Kluwe L, Fuensterer C, Kentsch M, Friedrich RE, Mautner VF. Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits. J Pediatr. 2011;159(4):652-5.e2. https://doi.org/10.1016/j.jpeds.2011.04.008. Epub 2011 May 31.

Article  PubMed  Google Scholar